We observed a 73-year-old man with necrobiotic xanthogranuloma (NXG) on the eyelids and concurrent multiple myeloma. The treatment was surgery followed by administration of melphalan. No relapse was seen in 19 months of follow-up. We consider that surgical removal of xanthogranuloma is an advisable rapid treatment that involves fewer side-effects than other treatments.
systemic immunosuppressive therapy with azathioprine or cyclosporin is limited by their adverse effects, or when the lesions are not controlled by systemic drugs alone. References1 Moschella SL. Neutrophilic dermatoses. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Mosby, London, 2003: 415 -418. 2 Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-283. 3 Mrowietz U. Ascomycin macrolactams. J Cutan Med Surg 2001; 5: 22-25. 4 Zuberbier T, Chong SU, Grunow K et al. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 2001; 108: 275-280. 5 Lazarus GS, Rocklin RE, David JR. Pyoderma gangrenosum, altered delayed hypersensitivity, and polyarthritis. Arch Dermatol 1972; 105: 46-51. 6 Norris DA, Weston WI, Thorne G, Humbert JR. Pyoderma gangrenosum: abnormal monocyte function corrected in vitro with hydrocortisone. Arch Dermatol 1978; 114: 906 -911. 7 Chiba T, Isomura I, Suzuki A, Morita A. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 2005; 32: 199 -203. 8 Groves RW, Allen MH, Ross EL, Barker JNWN, MacDonald DM. Tumour-necrosis factor alpha is proinflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995; 132: 345-352. 9 Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 2004; 122: 673-684. 10 Billich A, Aschauer H, Aszòdi A, Stuetz A. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004; 269: 29-35.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.